n"Nov 10 Sun Pharmaceutical Industries Ltd * Says approves scheme of amalgamation of Sun Pharma Medisales, Ranbaxy Drugs Ltd, Gufic Pharma, Vidyut Investments into co Source text: bit.ly/2g0Jbpb Further Reuters UK, 3 weeks ago
BRIEF-Rajasthan Cylinders & Containers Sept-qtr profit rises - Reuters India, 3 weeks ago
Backed by a Bombay High Court order, drug major Sun Pharmaceutical Industries today said it will release salaries of the erstwhile Ranbaxy medical representatives only if they used a company provided software application to report daily activity ...Business Standard, 1 month ago
Email this Print The management of Sun Pharmaceutical Industries has been asked by the office of the assistant labour commissioner, Maharashtra, to come over for a discussion on October 18 with medical representatives (MRs) of the erstwhile ...Smart Investor, 1 month ago
, the courts upheld a favorable verdict for AstraZeneca and Ranbaxy, ruling that the companies did not violate antitrust laws several years ago with an alleged pay for delay deal. But these two drug makers aren't the only winners. The ruling is a ...Uranium Investing News, 1 week ago AstraZeneca, Ranbaxy prevail in landmark pay-for-delay case FiercePharma, 1 week ago ASTRAZENECA : U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust trial 4 Traders, 1 week ago U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust ... Investing.com, 1 week ago
Finasteride Market: Industry Analysis Report, Regional Outlook, Application Development Potential & Forecast, 2016 2024.
"Finasteride market share comprises of Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Dr. Reddys Laboratories and Intas Pharmaceuticals, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, ...Digital Journal, 1 week ago
Pharmaceutical industry CONTINUED FROM MONDAY The competitiveness issues where Nigeria has consistently scored low include infrastructure, access to finance, security, corruption and governance, quality of education, skilled manpower and ...Sudan News Gazette, 3 days ago Pharmaceutical industry and national development - Part 2 The Guardian Nigeria, 3 days ago
More from: , Abbeylist.com...and 1 other sources
The $4.6 billionSun Pharmaceutical Industries has been at the forefront of the Indian pharma growth story, which has evolved from the sale of low-cost medicines in the largest markets to competing with the largest generic companies globally.4 Traders, 5 days ago ET 500: Sun Pharma strong and healthy Economic Times, 5 days ago
HAWTHORNE, N.Y.--( BUSINESS WIRE )-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today the appointment of Mr. Uday Baldota as Chief Executive Officer and as a nominee to Taro's Board of Directors. He is expected to begin his role as ...Citybizlist, 1 week ago Taro Announces Appointment of New CEO and New Board Member Nominations Business Wire, 1 week ago TARO PHARMACEUTICAL INDUSTRIES : Announces Appointment of New CEO and New Board Member Nominations 4 Traders, 1 week ago Taro Taps Sun Pharma CFO as New CEO BioSpace, 1 week ago
MUMBAI (NewsRise) -- Sun Pharmaceutical Industries has named company veteran and Chief Financial Officer Uday Baldota as the new chief executive of its U.S. unit, as India's largest drug maker braces for challenging times in its biggest market amid ...Nikkei Asian Review, 1 week ago
Israel's Taro Pharmaceutical Industries, a subsidiary of Sun Pharma, has appointed Uday Baldota its chief executive officer (CEO). Baldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about ...Moneycontrol.com, 1 week ago
on your WebpageAdd Widget >Get your members hooked!